<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>M.D</roleName><forename type="first">Sei-Jong</forename><surname>Kim</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Chonnam National University Medical School</orgName>
								<address>
									<addrLine>8 Hak-Dong, Dong-ku</addrLine>
									<postCode>501-757</postCode>
									<settlement>Kwangju</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:25+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INT RO DUCT IO N</head><p>Recent studies have revealed a structurally related family of secreted metalloproteinases which degrade extracellular matrix (ECM) components, such as collagens , fibronectin, laminin and proteoglycans with different substrate specificities. Matrix metalloproteinases (MMPs), including collagenase, gelatinase, stromelysin and membrane-type MMP have been implicated in the remodeeing of ECM, including basement membrane 1 ) . ECM remodeling is associated with physiological and pathological processes , including wound healing, angiogenesis, hepatic fibros is and, more notably, tumor invas ion and metastasis <ref type="bibr">2 -6 )</ref> .</p><p>Hepatic fibrosis is not caused solely by an increase in connective tissue synthes is but is bas ically the result of an imbalance between enhanced ECM synthesis and diminished or altered ECM breakdown 7 -1 0 ) . An essential step in the process of tumor invas ion and metastasis involves the degradation of ECM, including basement membrane. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>De p a rt m e nt o f Int e rna l M e d ic in e a n d Pat ho lo g y *, Ch o n na m N at io na l U n iv e rs ity M e d ica l S c ho o l, Kw a ngj u , Ko re a B a c kg ro u n d : M a t rix m e t a llo p ro t e in a s e s ( M M Ps ) h av e b e e n im p lic a t e d in t h e re m o d e llin g o f e x t ra c e llu la r m a t rix ( EC M ) , in c lu d in g b a s e m e nt m e m b ra n e . E C M re m o d e llin g is a s s o c ia t e d w it h p at h o lo g ic a l p ro c e s s e s , in c lu d in g h e p a t ic f ib ro s is , t u m o r inv a s io n a n d m e t a s t a s is . T is s u e in h ib t o rs o f m e t a llo p ro t e in a s e (T IM P) -1 a n d T IM P -2 w e re k n o w n t o in h ib it M M P -9 a n d M M P -2 , re s p e c t iv e ly . In t h e p re s e n t s t u d y , w e e x a m in e d t h e e x p re s s io n o f T IM P -1 a n d T IM P-2 in s u rg ic a l s p e c im e n p a irs o f h e p at o c e llu la r c a rc in o m a a n d n o nt u m o ra l liv e r a n d t h e c o rre lat io n b e tw e e n t h e ir e x p re s s io n a n d c lin ic o p at h o lo g ic a l c h a ra ct e ris t ic s . M e t h o d s : T h e lo c a liz a t io n o f b o t h t ra n s c rip t s a n d p ro t e in o f T IM P -1 a n d T IM P -2 w a s s t u d ie d by u s ing in s it u hy b rid iz at io n a n d im m u n o h is t o c h e m is t ry . R e s u lt s : T IM P -1 a n d T IM P -2 m R N A t ra n s c rip t s w e re f o u n d in t u m o r c e lls , h e p a t o cy t e , s in u s o id a l c e lls , e n d o t h e lia l c e lls a n d s t ro m a l c e lls . S ig n a l int e n s ity o f T IM P -1 w a s s t ro ng e r t h a n t h a t o f T IM P-2 . T h e re s u lt s o f im m u n o h is t o c h e m ic a l s t a in ing s w e re c o n c o rd a nt w it h t h o s e o b t a in e d by in s it u hy b rid iz a t io n . Ex p re s s io n o f T IM P -1 a n d T IM P -2 w a s o b s e rv e d in t u m o ro u s t is s u e , in n o nt u m o ro u s t is s u e a n d in t h e p o rt io n s o f t h e t u m o rs a dj a c e nt t o t h e c a p s u le s . Ho w e v e r, a c le a r d if f e re n c e in T IM P -1 a n d T IM P-2 m R N A e x p re s s io n w a s n o t o b s e rv e d a m o n g t h e t h re e t is s u e ty p e s . T h e int e n s ity o f T IM P -2 e x p re s s io n w a s g e n e ra lly w e a k e r t h a n t h a t o f T IM P -1 , a n d t h e in t e n s ity o f T IM P -1 a n d T IM P -2 m R N A e x p re s s io n d id n o t c o rre lat e w it h v a ria b le c lin ic o p at h o lo g ic a l c h a ra c t e ris t ic s . C o n c lu s io n : T IM Ps w a s e x p re s s e d in t u m o r c e lls a n d m a ny c e ll ty p e s o f t h e n o nt u m o ra l liv e r. F u rt h e r inv e s t ig a t io n s f o r T IM Ps ' u n k n o w n f u n c t io n a l ro le a re n e e d e d .</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ke y W o rd s : T is s ue in h ib it o r o f m e t a llo p ro t e inas e s ; Ca rc ino m a , He p at o ce llu la r; In s it u hy b rid iz at io n ; Im m u n o h is t o c h e m is t ry</head><p>Most forms of chronic liver disease are associated with the development of hepatic fibros is and cirrhosis. Hepatocellular carcinoma frequently occurs in hepatitis B or C virus-related chronic hepatitis or cirrhosis . In particular, cirrhosis has been regarded as a high-risk factor for developing hepatocellular carcinoma.</p><p>A large body of evidence indicates that MMPs play a crucial role in hepatic fibrosis, and enhanced MMPs activity has been associated with increases in invas ive and metastatic potential in many types of human carcinoma, including hepatocellular carcinoma 1 1 -1 4 ) .</p><p>In general, a number of control mechanisms exist to regulate MMPs activity in tissues. These mechanisms operate at different levels, including gene transcription, proenzyme activation and inhibition of activated enzymes. The latter mechanisms are regulated by tissue inhibitors of metalloproteinases (TIMPs), which bind to the catalytic site of the active enzyme as well as to the carboxyl terminus of the proenzyme, thereby inhibiting its activity and preventing its activation 15 -1 8 ) .</p><p>TIMPs bind strongly and stoicheometrically to active form of MMPs and inactivate them. TIMP-1 and TIMP-2 also form tight binding complexes with proMMP-9 and proMMP-2, respectively, to inhibit their activation 1 5 <ref type="bibr">-18 )</ref> . The imbalance of MMPs and TIMPs may contribute to the pathogenesis of hepatic fibrosis and tumor invasion and metastasis. Therefore, it is important to understand the role of TIMPs in hepatocellular carcinoma.</p><p>We examined localization of both transcripts and protein of TIMP-1 and TIMP-2 in s urgical specimen pairs of hepatocellular carcinoma and nontumoral liver using in situ hybridization and immunohistochemistry, and compared it with clinicopathological characteristics .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MAT E R IA LS A ND MET HO DS 1. Tumor s pecimens</head><p>Formalin-fixed, paraffin-embedded tissue blocks were obtained from 25 patients who underwent surgery for hepatocellular carcinoma at Chonnam National University Hospital from January 1997 to December 1998. All pathologic slides were reviewed and adequate blocks that showed the junction between tumorous a nd adjacent nontumorous live r tiss ue we re se lected.</p><p>The study group consisted of 25 patients with hepatocellular carcinoma (19 men and 6 women; age</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ta ble 1. C lin ic o p a tho lo g ic a l p a ra me te rs o f 2 5 patie nts w ith he pato ce llula r ca rc ino ma</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Parameters</head><p>No. of cases(%) Tumor size (range, 2-9 cm; median, 4.5 cm) was less than 4.5cm in 16 patients and &gt;4.5cm in 9 patients.</p><p>The grade of tumor differentiation was as follows: well differentiated in 4 patients, moderately differentiated in 12 patients, and poorly differentiated in 9 patients. Tumors were infiltrative in 9 patients and encapsulated in 16 patients. Capsular invas ion was present in 5 of the 16 patients with encapsulated tumors, and satellite nodules were present in 10 patients, with vascular invasion detected in 8 patients <ref type="table">(Table 1)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">In situ hybridization</head><p>For in s itu hybridization, two biotinylated oligonucleotide probes complementary to TIMP-1 (TGTGG-GTGGGGTGGGACACAGGTGC) and TIMP-2 (CCA-CTTCCTTCTCACTGACCGC) mRNA were synthesized. All in situ hybridization experiments were carried out using manual capillary action technology on the Micro-Probe staining system (Fisher Scientific, Pittsburgh, PA) with the modified one-hour method of Park et al 1 9 ) . Briefly, the slides were rapidly deparaffinized, cleared and rehydrated. The tissues were then digested with pepsin (Sigma, St. Louis, MO) at 2 mg/mL for 1 minute at 110 . The probe was applied to the s lides and the tiss ues were heated at 110 for 10 minutes to denature any seconda ry mRNA structures . The hybridization of the probe a nd mRNA target was performed by exposing the slides to a microwave oven in which the te mperature was gradually decreased from 110 to 45 (110 for 1 min, 95 for 7 min, 85 for 7 min, 65 for 5 min, 45 for 20 minutes , res pectively). The biotinylated hybrids were detected with stre ptavidin-horse radis h peroxidase (Zymed, Sa nFra ncisco, CA) for 7 minutes at 45 . Afte r pre incubation in 3-amino-9-ethylcarbazole (AEC, S igma, St. Louis, MO) for 7 minutes at 45 , the tiss ues we re was hed with distilled wate r. Following the chromogen reaction, the tiss ues were counte rsta ined with hematoxylin solution (Research Ge netics, Huntsville , AL), washed with distilled water, air-dried and cove r-slipped with Universal mount (Resea rch Ge netics , Huntsville, AL). In situ hybridization for negative control was performed with probe diluent in hybridization. To eva luate the degree of TIMP-1 and TIMP-2 mRNA expression in tumor tiss ue , the sta ining inte ns ity was divided into the following three groups ; 0, negative s igna l; 1, wea k signal; 2, strong s igna l. Assess ment of express ion was eva luated by two independent observers without knowledge of the clinical outcomes . Consens us scores we re ass igned for each case by reviewing the s lides with discrepancies in scoring. All sections on which the two observers disagreed were re-evaluated and after discuss ion there was total agreement on the classification.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Immunohistoche mistry</head><p>All procedures for immunohistochemical staining were done by the Micro-Probe staining system (Fisher Scientific, Pittsburgh, PA) based on capillary action 2 0 ) . Paraffin sections of 4 m in thickness with mounted probe on slides were immunostained with anti-mouse monoclonal antibodies for TIMP-1 and TIMP-2 antigens (NeoMarkers, Union, CA) by the avidin-biotin peroxidase complex method 2 0 ) . Sections were dewaxed using absolute alcohol. Antigen retrieval was performed by microwave for 7 minutes in citrate buffer (2.1g/L monohydrate citric acid in distilled water, pH 6.0). After three washes in universal buffer, the slides were immersed in 0.6% hydrogen peroxide for 5 minutes to block the endogenous peroxidase activity. The primary antibodies, used at concentrations of 1:120, 1:100 respectively, were diluted in phosphatebuffered saline supplemented with 5% normal horse serum and 1% bovine serum albumin and then incubated with tissues overnight at room temperature. The slides were washed in universal buffer and incubated with biotinylated affinity-purified anti-mouse immunoglobulin G (Sigma, St. Louis, MO) for 7 minutes at 45 . After three washes with universal buffer, streptavidin-alkaline phosphatase detection system (Biomeda, Foster, CA) was applied for 7 minutes. As the final step, the slides were developed for 15 minutes with the enzyme substrate, 3 amino-9-ethyl carbazole (AEC, Sigma, St. Louis, MO), and counterstained with hematoxylin solution for 1 minute (Research Genetics, Huntsville, AL). After dehydration, the tissue was sealed with a universal mount (Research Genetics, Huntsville, AL).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Statistical Analys is</head><p>Significant bivariate associations were tested for all study variables by 2 test and Fisher's exact test. The statistical software program used was Statistical Package for the Social Sciences (SPSS/PC+ 8.0, Chicago, IL, USA). A p -value of less than 0.05 was accepted as statistically significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>R ES ULT S</head><p>1. Express ion of TIMP-1 a nd TIMP-2 mRNA TIMP-1 and TIMP-2 mRNA were detected in all hepatocellular carcinoma cases examined. Hybridization signals for TIMP-1 and TIMP-2 mRNA were detected in tumorous tissue, in nontumorous tissue and in the portions of the tumors adjacent to the capsules . However, a clear difference in TIMP-1 and TIMP-2 mRNA expression was not observed between tumorous tiss ue, nontumorous tissue and the portions of the tumors adjacent to the capsules. In nontumorous portion, hybridization signals for TIMP-1 and TIMP-2 mRNA were detected in hepatocytes, bile duct cells, sinusoidal lining cells and stromal cells <ref type="figure">(Figure 1 A, B)</ref>. The expression of TIMP-1 and TIMP-2 mRNA in tumor cells was located in the cytoplasm and showed a diffuse or granular pattern <ref type="figure" target="#fig_3">(Figure 2 A, B)</ref>. Intensity of expression varied among cases and in different areas of the same tumor. With regard to signal intensity of TIMP-1 mRNA, 12 of the cases were weak and 13 were strong <ref type="table">(Table 2)</ref>. With regard to signal intensity of TIMP-2 mRNA, 15 of the cases were weak and 10 were strong <ref type="table">(Table 3)</ref>. Howeve r, the inte ns ity of TIMP-2 expres s ion was generally weaker than TIMP-1.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Express ion of TIMP-1 a nd TIMP-2 prote in</head><p>Immunohistochemical study was also performed for identifying the cellular localization of TIMP-1 and TIMP-2 proteins. In all hepatocellular carcinoma tissues ,  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Correlation between TIMP-1 and TIMP-2 mRNA expression and clinicopathological parameters</head><p>We tested the relationships between intens ity of TIMP-1 and TIMP-2 mRNA expression in tumorous tiss ue and the following clinicopathological parameters: tumor size, grade of differentiation, pattern of growth, capsule invas ion, presence of satellite nodules , basal liver diseases and vascular invasion. There was no correlation between intensity of TIMP-1 and TIMP-2 mRNA expression in tumorous tissue and all clinicopathological parameters <ref type="table">(Table 2, Table 3</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>D IS C US S IO N</head><p>Hepatic fibrosis and cirrhos is are associated with excessive deposition of ECM in a distribution and compos ition different from the non-fibrotic organ 9 , 1 0 ) . These alterations relate particularly to an absolute and re lative accumulation of collage n types I a nd III in Disordered MMP activity could theoretically contribute to such pathological states as progressive hepatic fibros is and cirrhosis. Advanced hepatic fibrosis and cirrhosis are generally considered to be irreversible conditions even after removal of the injurious agent. Moreover, the development of cirrhosis is characterized by a diminution of liver MMPs activity, implying that the capacity of the diseased liver to remodel the fibrotic matrix is cortically reduced. In studies undertaken to measure MMPs activity in hepatic fibrosis, a general pattern emerges. Initially there is a reversible phase with active ECM remodelling and detectable MMPs activity. In late disease, fibrosis becomes irreversible and, at this point, MMPs activity falls 2 2 -2 5 ) .</p><p>These changes of MMPs activity operate at different levels and control the synthesis of the proenzyme, the secretion of the proenzyme that requires activation and the presence of the metalloproteinases inhibitors. First, all of them are secreted in latent forms (proen-zyme) and must be activated for the express ion of their activities. Second, the metalloproteinase activities are regulated by common metalloproteinase inhibitors secreted from various types of cells, such as connective tissue cells , vascular endothelial cells and tumor cells.</p><p>Our study showed that, in nontumorous portion with either chronic hepatitis or cirrhosis, expression of TIMP-1 and TIMP-2 were detected in many cell types, including hepatocytes, bile duct cells, sinusoidal lining cells and stromal cells. These results suggest that TIMP-1 and TIMP-2 might be involved in hepatic fibros is and cirrhosis. Previous reports demonstrated that express ion of TIMP-1 and TIMP-2 was increased in human cirrhotic livers in comparison to normal liver 2 6 ,2 7 ) . Furthermore, Fukuda et al reported that the expression of TIMP-1 was observed in fibrous tissue, especially in the capsule of hepatocellular carcinoma 2 8 ) . These results may indicate a relationship between the increased expression of TIMP-1 and hepatic fibros is, as well as a relations hip between such increased expression and the hepatocellular carcinoma capsule formation.</p><p>Iredale et al reported that the cellular distribution of TIMP-1 and TIMP-2 appear to be similar, although only TIMP-1 is generally found in large amounts 2 9 ) . Our study also showed that a clear difference in TIMP-1 and TIMP-2 express ion was not observed between tumorous tissue, nontumorous tissue and the portions of the tumors adjacent to the caps ules, and the intensity of TIMP-2 expression was generally weaker than TIMP-1.</p><p>In general, an important step in tumor invasion and metastasis is the proteolytic breakdown of ECM in normal tissue surrounding the tumor. Among proteolytic enzymes, the MMPs are the most critical part of this step.</p><p>TIMPs concomitantly secreted into the cellular microenvironment interact with MMPs at several levels to stabilize latent enzymes , inhibit active enzymes and modulate the binding of soluble MMPs to surfacebound MMPs , and thereby control the net MMPs activity. Therefore, TIMPs are critica l in regulating ECM degradation a nd tumor invas ion and metastas is. Although some studies s uggest a role of TIMPs in preve nting tumor invas ion, othe rs s how a complex re lations hip betwee n MMPs a nd TIMPs in which the TIMPs we re not shown to prevent tumor invas ion 3 0 -3 4 ) .</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>Ex p r e s s io n o f T is s u e In h ib it o rs of M e t a llo p r o t e in a s e s (T IM P s ) in He p a t o c e llu la r C a r c in o m a Yo u n g -Eu n J o o , M .D. , Yo u n g -Ho S e o , M .D. , W a n-S ik Le e , M .D. Hy u n-S o o Kim , M .D. , S u n g -Ky u C h o i, M .D. , J o n g -S u n Re w , M .D. C h a n g -S o o P a rk, M .D.* a n d S e i-J o n g Kim , M . D.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Ta ble 2 .*Fig ure 1 .</head><label>21</label><figDesc>Co rre latio n be twe e n expre s s io n of TIMP-1 mRNA a nd c linico patho lo g ica l pa ra me te rs of he pato-WD; well differentiated, MD; moderately differentiated, PD; poorly differentiated Detection of TIMP-1 and TIMP-2 mRNA by in situ hybridization in nontumorous portion surrounding hepatocellular carcinoma. Hybridization signals for TIMP-1 and TIMP-2 mRNA are detected in hepatocytes , bile duct cells, sinusoidal lining cells and stromal cells(X 200). (A) TIMP-1, (B) TIMP-2</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Ta ble 3 .</head><label>3</label><figDesc>Co rre latio n be twe e n expre s s io n of TIMP-2 mRNA a nd c linico patho lo g ica l pa ra me te rs of he patowell differentiated, MD; moderately differentiated, PD; poorly differentiated there was a clear immunoreactivity with TIMP-1 and TIMP-2 antibodies . Express ion and location of TIMP-1 and TIMP-2 protein, as indicated by immunostaining, correlated well with in situ hybridization analysis of mRNA transcripts. TIMP-1 and TIMP-2 were expressed in tumor cells and tumor stroma. TIMP-1 and TIMP-2 immunoreactivities in tumor stroma were situated in fibroblasts, leukocytes, endothelial cells and ECM(Figure 3 A, B).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig ure 2 .</head><label>2</label><figDesc>Detection of TIMP-1 and TIMP-2 mRNA by in situ hybridization in hepatocellular carcinoma. The expression of TIMP-1 and TIMP-2 m RNA in tumor cells is located in the cytoplasm and s hows a diffuse or granular pattern (X 200). (A) TIMP-1, (B) TIMP-2</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig ure 3 .</head><label>3</label><figDesc>Immunoreactivity of TIMP-1 and TIMP-2 in hepatocellular carcinoma. The tumor cells express TIMP-1 and TIMP-2 in the cytoplasm. The stromal cells also express TIMP-1 and TIMP-2 (X 200). (A) TIMP-1, (B) TIMP-2 fibrotic and cirrhotic livers 2 1 ) .</figDesc></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This paradoxica l res ult indicates that TIMP-1 a nd TIMP-2 also exhibit othe r roles than the inhibition of MMPs , which may affect the maligna nt pote ntial. Hayakawa et a l 3 5 ,3 6 ) re ported that TIMP-1 a nd TIMP-2 molecules have growth promoting activity. Howeve r, it re mains unclea r whethe r TIMPs stimulate the growth of hepatoce llula r carcinoma ce lls . In our study, a clear difference in TIMP-1 and TIMP-2 expression was not obse rved between tumorous tiss ue, nontumorous tiss ue and the portions of the tumors adjace nt to the ca ps ules . Also, inte ns ity of TIMP-1 and TIMP-2 mRNA expression did not correlate with variable clinicopathological characteristics. The effect of TIMPs on tumor invasion a nd metastas is a re pa rticularly complex. TIMPs synthesis has been known to be regulated by growth factors a nd cytokines such as tra nsforming growth factor-1, inte rle ukin and tumor necros is factor-3 7 ,3 8 ) .</p><p>The influence of other genes, such as those coding for growth factors and metastasis suppressor and dominant metastas is genes , on the possible modulation of MMP/TIMP, together with possible repercussions for the invas ive and metastatic properties of the cancer cell, also needs to be studied in depth.</p><p>In summa ry, expression of TIMP-1 a nd TIMP-2 was found in tumor ce lls , hepatocyte , s inusoidal cells, e ndothe lia l ce lls a nd stroma l ce lls . Express ion of TIMP-1 a nd TIMP-2 was observed in tumorous tiss ue, in nontumorous tiss ue and in the portions of the tumors adjacent to the capsules . Express ion of TIMP-1 was stronge r than that of TIMP-2 and inte ns ity of TIMP-1 a nd TIMP-2 mRNA express ion did not corre late with va ria ble clinicopathologica l cha racteristics .</p><p>Further investigations for TIMPs' unknown functional role are needed. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C KNO W LE DG E ME NTS</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">temporal regulation of extracellular matrix degradation at the cell s urface</title>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Cell Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="731" to="738" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Proteolytic remodeling of extracellular matrix</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Birkedal-Hansen</surname></persName>
		</author>
		<idno type="DOI">10.1016/0955-0674(95)80116-2</idno>
		<idno type="PMID">8573349</idno>
		<idno type="PII">0955-0674(95)80116-2</idno>
		<idno type="ark">ark:/67375/6H6-N1G5T384-V</idno>
		<idno type="istexId">4BEEDD83EECFDB3DCA05EE18D15B0E8796CBE7C4</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Cell Biology</title>
		<idno type="ISSN">0955-0674</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="728" to="735" />
			<date type="published" when="1995" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Cy tokine regulation of matrix metalloproteinase activit y and its regulatory dysfunction in disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">E</forename><surname>Petrides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Chem H-S</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="page" from="345" to="355" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A utom ated molecular pathology : one hour in situ hybridiz ation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pa</forename><surname>Rk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ma</forename><surname>Naha N</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Brigati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Histotechnol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="462" to="467" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Complete one-hour imm unohistochemistry bas ed on capillary action</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pa</forename><surname>Ma Naha N Lj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Rk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Brigati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechniques</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="434" to="443" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Increase in type I and type III collagens in human alcoholic liver cirrhosis.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Rojkind</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Martinez-Palomo</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.73.2.539</idno>
		<idno type="PMID">1061156</idno>
		<idno type="PMCID">PMC335945</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/73/2/539.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="539" to="543" />
			<date type="published" when="1976-02-01" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katsuya</forename><surname>Maruyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lawrence</forename><surname>Feinman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zev</forename><surname>Fainsilber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayuki</forename><surname>Nakano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Isao</forename><surname>Okazaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">S</forename><surname>Lieber</surname></persName>
		</author>
		<idno type="DOI">10.1016/0024-3205(82)90023-6</idno>
		<idno type="PMID">6283291</idno>
		<idno type="PII">0024-3205(82)90023-6</idno>
		<idno type="ark">ark:/67375/6H6-55L5M6VG-9</idno>
		<idno type="istexId">0441831D40D72BA9B3426580BE9F4BCFFA4280D8</idno>
	</analytic>
	<monogr>
		<title level="j">Life Sciences</title>
		<title level="j" type="abbrev">Life Sciences</title>
		<idno type="ISSN">0024-3205</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1379" to="1384" />
			<date type="published" when="1982-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Collagenase in experimental carbon tetrachloride cirrhosis of the liver</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Montfort</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Perez-Tamayo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="11" to="420" />
			<date type="published" when="1978" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Collagenase and Collagenolytic Cathepsin in Normal and Fibrotic Rat Liver</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshikazu</forename><surname>Murawaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sadako</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahiko</forename><surname>Koda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chisato</forename><surname>Hirayama</surname></persName>
		</author>
		<idno type="DOI">10.1093/oxfordjournals.jbchem.a123187</idno>
		<idno type="PMID">2172225</idno>
		<idno type="ark">ark:/67375/HXZ-749GS0PN-W</idno>
		<idno type="istexId">B4EEF5F701F535881180448B6F594248788E1459</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Biochemistry</title>
		<idno type="ISSN">0021-924X</idno>
		<idno type="ISSNe">1756-2651</idno>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="241" to="244" />
			<date type="published" when="1990-08" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Collagenolytic activity in experimental cirrhosis of the liver</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruy</forename><surname>Perez-Tamayo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irmgard</forename><surname>Montfort</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elvira</forename><surname>Gonzalez</surname></persName>
		</author>
		<idno type="DOI">10.1016/0014-4800(87)90015-3</idno>
		<idno type="PMID">2824236</idno>
		<idno type="PII">0014-4800(87)90015-3</idno>
		<idno type="ark">ark:/67375/6H6-1CWV7FWD-9</idno>
		<idno type="istexId">DD36D4D8A8621C8B55E5536987C568224DE213E1</idno>
	</analytic>
	<monogr>
		<title level="j">Experimental and Molecular Pathology</title>
		<title level="j" type="abbrev">Experimental and Molecular Pathology</title>
		<idno type="ISSN">0014-4800</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="300" to="308" />
			<date type="published" when="1987-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Benyon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Iredale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Goddard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Winwood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Arthur</surname></persName>
		</author>
		<idno type="DOI">10.1053/gast.1996.v110.pm8608892</idno>
		<idno type="PMID">8608892</idno>
		<idno type="PII">S0016-5085(96)00127-8</idno>
		<idno type="ark">ark:/67375/6H6-RX8MJ9KB-R</idno>
		<idno type="istexId">932AC9FF953B70C04A19209C85B0F3461CDF761E</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<title level="j" type="abbrev">Gastroenterology</title>
		<idno type="ISSN">0016-5085</idno>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="821" to="831" />
			<date type="published" when="1996-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Orzechows ki HD, Bechste in WO , Ne uha us P , Gres s ne r AM, S chuppa n D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Herbst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Wege</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Milani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Pellegrini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="1647" to="1659" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshihide</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masami</forename><surname>Imoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuo</forename><surname>Koyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuuji</forename><surname>Miyazawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Isao</forename><surname>Nakano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masami</forename><surname>Hattori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fumihiro</forename><surname>Urano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shuji</forename><surname>Kodama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazushi</forename><surname>Iwata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taro</forename><surname>Hayakawa</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf02779506</idno>
		<idno type="PMID">1848826</idno>
		<idno type="ark">ark:/67375/1BB-JCFBMQ80-N</idno>
		<idno type="istexId">499A5E206464B91CD83CAE81C732FE49FCDC27AE</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterologia Japonica</title>
		<title level="j" type="abbrev">Gastroenterol Jpn</title>
		<idno type="ISSN">0435-1339</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="37" to="41" />
			<date type="published" when="1991-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Tissue inhibitors of metalloproteinases in liver fibrosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ireda Le</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1357-2725(96)00118-5</idno>
		<idno type="PMID">9076940</idno>
		<idno type="PII">S1357-2725(96)00118-5</idno>
		<idno type="ark">ark:/67375/6H6-G9G541C2-4</idno>
		<idno type="istexId">EE0D849697AF3E1A40B53EB8DEE5212C9446EEB0</idno>
	</analytic>
	<monogr>
		<title level="j">The International Journal of Biochemistry &amp; Cell Biology</title>
		<title level="j" type="abbrev">The International Journal of Biochemistry &amp; Cell Biology</title>
		<idno type="ISSN">1357-2725</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="54" />
			<date type="published" when="1997-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Inhibition of invasion and m etas tasis in cells transfected with an inhibitor of metalloproteinases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">A</forename><surname>De C Le Rk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Hima Da</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Boo Ne Tc</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">La</forename><surname>Ke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Taylor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="701" to="708" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Suppression of the Tumorigenic and Metastatic Abilities of Murine B16-F10 Melanoma Cells In Vivo by the Overexpression of the Tissue Inhibitor of the Metalloproteinases-1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Khokha</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/86.4.299</idno>
		<idno type="PMID">8158685</idno>
		<idno type="ark">ark:/67375/HXZ-CD132F2K-V</idno>
		<idno type="istexId">699FD94B697C2839B32FFAD9478B2A3513EE0059</idno>
	</analytic>
	<monogr>
		<title level="j">JNCI Journal of the National Cancer Institute</title>
		<title level="j" type="abbrev">JNCI Journal of the National Cancer Institute</title>
		<idno type="ISSN">0027-8874</idno>
		<idno type="ISSNe">1460-2105</idno>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="299" to="304" />
			<date type="published" when="1994-02-16" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Inhibition of S V40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Ma Rtin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruthe</forename><forename type="middle">R</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Sa Nchez-Sweatma N</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">H</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">W</forename><surname>Khokha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="569" to="576" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><forename type="middle">W</forename><surname>Visscher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matti</forename><surname>Höyhtyä</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">K</forename><surname>Ottosen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi-Ming</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fazlul</forename><forename type="middle">H</forename><surname>Sarkar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">D</forename><surname>Crissman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rafael</forename><surname>Fridman</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.2910590308</idno>
		<idno type="PMID">7927938</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<idno type="ISSNe">1097-0215</idno>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="339" to="344" />
			<date type="published" when="1994-11-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Enhanced RNA expression of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) in human breast cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hitoshi</forename><surname>Yoshiji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><forename type="middle">E</forename><surname>Gomez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Unnur</forename><forename type="middle">P</forename><surname>Thorgeirsson</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1097-0215(19960422)69:2&lt;131::aid-ijc11&gt;3.3.co;2-x</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<idno type="ISSNe">1097-0215</idno>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="131" to="134" />
			<date type="published" when="1996-04-22" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells A possible new growth factor in serum</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taro</forename><surname>Hayakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoko</forename><surname>Yamashita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiko</forename><surname>Tanzawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ekuko</forename><surname>Uchijima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazushi</forename><surname>Iwata</surname></persName>
		</author>
		<idno type="DOI">10.1016/0014-5793(92)80015-9</idno>
		<idno type="PMID">1544418</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Letters</title>
		<idno type="ISSN">0014-5793</idno>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="29" to="32" />
			<date type="published" when="1992-02-17" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2(TIMP-2)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Hayakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Yamashita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ohuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Shinagawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Sci</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="2373" to="2379" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Modulation by interleukin 1 and tumor necrosis factor α of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Véronique</forename><surname>Lefebvre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chantal</forename><surname>Peeters-Joris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gilbert</forename><surname>Vaes</surname></persName>
		</author>
		<idno type="DOI">10.1016/0167-4889(90)90145-4</idno>
		<idno type="PMID">2162214</idno>
		<idno type="PII">0167-4889(90)90145-4</idno>
		<idno type="ark">ark:/67375/6H6-VKWZ6KHX-Z</idno>
		<idno type="istexId">67BAC898D5812DE6E37ADEC0B3833708FD5BB70B</idno>
	</analytic>
	<monogr>
		<title level="j">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</title>
		<title level="j" type="abbrev">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</title>
		<idno type="ISSN">0167-4889</idno>
		<imprint>
			<biblScope unit="volume">1052</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="366" to="378" />
			<date type="published" when="1990-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Localization of transforming growth factor-β isotypes in lesions of the human breast</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bryan</forename><forename type="middle">K</forename><surname>Mccune</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Mullin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathleen</forename><forename type="middle">C</forename><surname>Flanders</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">J</forename><surname>Jaffurs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Larry</forename><forename type="middle">T</forename><surname>Mullen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">B</forename><surname>Sporn</surname></persName>
		</author>
		<idno type="DOI">10.1016/0046-8177(92)90004-m</idno>
		<idno type="PMID">1544664</idno>
		<idno type="PII">0046-8177(92)90004-M</idno>
		<idno type="ark">ark:/67375/6H6-SSTBQ0T6-M</idno>
		<idno type="istexId">5A6671445AE290D41E4B800FA987F24660FE4E11</idno>
	</analytic>
	<monogr>
		<title level="j">Human Pathology</title>
		<title level="j" type="abbrev">Human Pathology</title>
		<idno type="ISSN">0046-8177</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="20" />
			<date type="published" when="1992-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
